東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Ovarian cancer biomarkers = mapping ...

El Bairi, Khalid.

FindBook

Google Book

Amazon

博客來

Ovarian cancer biomarkers = mapping to improve outcomes /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Ovarian cancer biomarkers/ edited by Khalid El Bairi.
其他題名:	mapping to improve outcomes /
其他作者:	El Bairi, Khalid.
出版者:	Singapore :Springer Singapore : : 2021.,
面頁冊數:	xv, 229 p. :ill. (some col.), digital ;24 cm.
內容註:	Chapter 1. General Overview of the Origins and Pathology of Ovarian Cancer -- Chapter 2_An Introduction to the Current Management of Ovarian Cancer in the Era of Precision Oncology -- Chapter 3_The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways and Predictive Biomarkers -- Chapter 4_Genetic Alterations in Ovarian Cancer as Prognostic and Predictive Biomarkers of Therapy Response and Surgical Outcomes -- Chapter 5_The Emergence of Circulating Tumor DNA in the Management of Ovarian Cancer -- Chapter 6_Proteomic Biomarkers for Early Detection and Patients' Stratification in Ovarian Cancer -- Chapter 7_Cutting-edge Technologies and Ovarian Cancer.
Contained By:	Springer Nature eBook
標題:	Ovaries - Cancer -
電子資源:	https://doi.org/10.1007/978-981-16-1873-4
ISBN:	9789811618734

Ovarian cancer biomarkers = mapping to improve outcomes /
Ovarian cancer biomarkersmapping to improve outcomes /[electronic resource] :edited by Khalid El Bairi. - Singapore :Springer Singapore :2021. - xv, 229 p. :ill. (some col.), digital ;24 cm.

Chapter 1. General Overview of the Origins and Pathology of Ovarian Cancer -- Chapter 2_An Introduction to the Current Management of Ovarian Cancer in the Era of Precision Oncology -- Chapter 3_The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways and Predictive Biomarkers -- Chapter 4_Genetic Alterations in Ovarian Cancer as Prognostic and Predictive Biomarkers of Therapy Response and Surgical Outcomes -- Chapter 5_The Emergence of Circulating Tumor DNA in the Management of Ovarian Cancer -- Chapter 6_Proteomic Biomarkers for Early Detection and Patients' Stratification in Ovarian Cancer -- Chapter 7_Cutting-edge Technologies and Ovarian Cancer.

This book comprehensively summarizes the biology, etiology, and pathology of ovarian cancer and explores the role of deep molecular and cellular profiling in the advancement of precision medicine. The initial chapter discusses our current understanding of the origin, development, progression and tumorigenesis of ovarian cancer. In turn, the book highlights the development of resistance, disease occurrence, and poor prognosis that are the hallmarks of ovarian cancer. The book then reviews the role of deep molecular and cellular profiling to overcome challenges that are associated with the treatment of ovarian cancer. It explores the use of genome-wide association analysis to identify genetic variants for the evaluation of ovarian carcinoma risk and prognostic prediction. Lastly, it highlights various diagnostic and prognostic ovarian cancer biomarkers for the development of molecular-targeted therapy.

ISBN: 9789811618734

Standard No.: 10.1007/978-981-16-1873-4doiSubjects--Topical Terms:

3521518
Ovaries
--Cancer

LC Class. No.: RC280.O8 / O83 2021

Dewey Class. No.: 616.99465

Ovarian cancer biomarkers = mapping to improve outcomes /
LDR:02602nmm a2200325 a 4500 001 2253363
003 DE-He213
005 20211009075454.0
006 m d
007 cr nn 008maaau
008 220327s2021 si s 0 eng d
020 $a 9789811618734 $q (electronic bk.)
020 $a 9789811618727 $q (paper)
024 7 $a 10.1007/978-981-16-1873-4 $2 doi
035 $a 978-981-16-1873-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.O8 $b O83 2021
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.99465 $2 23
090 $a RC280.O8 $b O96 2021
245 0 0 $a Ovarian cancer biomarkers $h [electronic resource] : $b mapping to improve outcomes / $c edited by Khalid El Bairi.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a xv, 229 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Chapter 1. General Overview of the Origins and Pathology of Ovarian Cancer -- Chapter 2_An Introduction to the Current Management of Ovarian Cancer in the Era of Precision Oncology -- Chapter 3_The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways and Predictive Biomarkers -- Chapter 4_Genetic Alterations in Ovarian Cancer as Prognostic and Predictive Biomarkers of Therapy Response and Surgical Outcomes -- Chapter 5_The Emergence of Circulating Tumor DNA in the Management of Ovarian Cancer -- Chapter 6_Proteomic Biomarkers for Early Detection and Patients' Stratification in Ovarian Cancer -- Chapter 7_Cutting-edge Technologies and Ovarian Cancer.
520 $a This book comprehensively summarizes the biology, etiology, and pathology of ovarian cancer and explores the role of deep molecular and cellular profiling in the advancement of precision medicine. The initial chapter discusses our current understanding of the origin, development, progression and tumorigenesis of ovarian cancer. In turn, the book highlights the development of resistance, disease occurrence, and poor prognosis that are the hallmarks of ovarian cancer. The book then reviews the role of deep molecular and cellular profiling to overcome challenges that are associated with the treatment of ovarian cancer. It explores the use of genome-wide association analysis to identify genetic variants for the evaluation of ovarian carcinoma risk and prognostic prediction. Lastly, it highlights various diagnostic and prognostic ovarian cancer biomarkers for the development of molecular-targeted therapy.
650 0 $a Ovaries $x Cancer $x Etiology. $3 3521518
650 0 $a Ovaries $x Cancer $x Genetic aspects. $3 864368
650 0 $a Biochemical markers. $3 587592
650 1 4 $a Cancer Research. $3 891172
650 2 4 $a Gene Expression. $3 600530
650 2 4 $a Molecular Medicine. $3 890952
700 1 $a El Bairi, Khalid. $3 3503457
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-16-1873-4
950 $a Biomedical and Life Sciences (SpringerNature-11642)